SpCas9 TadDE Citations (2)
Originally described in: Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity.Neugebauer ME, Hsu A, Arbab M, Krasnow NA, McElroy AN, Pandey S, Doman JL, Huang TP, Raguram A, Banskota S, Newby GA, Tolar J, Osborn MJ, Liu DR Nat Biotechnol. 2022 Nov 10. pii: 10.1038/s41587-022-01533-6. doi: 10.1038/s41587-022-01533-6. PubMed Journal
Articles Citing SpCas9 TadDE
| Articles |
|---|
| A base editor facilitates simultaneous purine and pyrimidine substitutions for ex vivo and in vivo mutagenesis screens. He Z, Xie Y, Huang H, Zhang Z, Feng S, Xu R, Chen X, Gao F, Li P, Zhu M, Wu S, Du X. Cell Chem Biol. 2025 Sep 18;32(9):1183-1196.e5. doi: 10.1016/j.chembiol.2025.08.003. Epub 2025 Sep 4. PubMed |
| Multiplex base editing of BCL11A regulatory elements to treat sickle cell disease. Fontana L, Martinucci P, Amistadi S, Felix T, Mombled M, Tachtsidi A, Corre G, Chalumeau A, Hardouin G, Martin J, Romano O, Amendola M, Antoniou P, Miccio A. Cell Rep Med. 2025 Oct 21;6(10):102376. doi: 10.1016/j.xcrm.2025.102376. Epub 2025 Sep 26. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.